BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37735697)

  • 21. Combined serum anti-SSA/Ro and salivary TRIM29 reveals promising high diagnostic accuracy in patients with primary Sjögren's syndrome.
    Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
    PLoS One; 2021; 16(10):e0258428. PubMed ID: 34624052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
    Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
    Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ; Kelder JC
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
    Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of primary Sjögren's syndrome related lymphocytic interstitial pneumonia.
    Dong X; Gao YL; Lu Y; Zheng Y
    Clin Rheumatol; 2021 Feb; 40(2):601-612. PubMed ID: 32613392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.
    Ramírez Sepúlveda JI; Kvarnström M; Eriksson P; Mandl T; Norheim KB; Johnsen SJ; Hammenfors D; Jonsson MV; Skarstein K; Brun JG; ; Rönnblom L; Forsblad-d'Elia H; Magnusson Bucher S; Baecklund E; Theander E; Omdal R; Jonsson R; Nordmark G; Wahren-Herlenius M
    Biol Sex Differ; 2017 Aug; 8(1):25. PubMed ID: 28789696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-SSA/SSB-negative primary Sjögren's syndrome showing different clinical phenotypes: a retrospective study of 934 cases.
    Chen J; He Q; Yang J; Wu T; Huang Z; Zhang Y; Liao J; Zhang L; Yu X; Yao C; Luo J; Tao Q
    Adv Rheumatol; 2023 May; 63(1):21. PubMed ID: 37189182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics.
    Kvarnström M; Ottosson V; Nordmark B; Wahren-Herlenius M
    Scand J Rheumatol; 2015; 44(2):135-42. PubMed ID: 25222653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated
    Liu Z; Li F; Pan A; Xue H; Jiang S; Zhu C; Jin M; Fang J; Zhu X; Brown MA; Wang X
    Front Immunol; 2019; 10():795. PubMed ID: 31068931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
    Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
    Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of primary Sjögren's syndrome-associated peripheral nervous system lesions.
    Zheng J; Zhang J; Jin Y; Wang Y; Xu L; Zheng H; Jiang H; Yuan C
    J Neurol; 2023 Nov; 270(11):5527-5535. PubMed ID: 37523064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjögren's syndrome.
    Min HK; Kim SH; Park Y; Lee KA; Kwok SK; Lee SH; Kim HR
    PLoS One; 2021; 16(11):e0259519. PubMed ID: 34731207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Ro52 Antibody as a Protective Factor for Pulmonary Fibrosis in Primary Sjögren's Syndrome.
    Li D; Li H; Li W; Zhu T
    Iran J Immunol; 2022 Jun; 19(2):161-171. PubMed ID: 35767889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsa_circ_0008301 as a potential biomarker of disease activity for primary Sjogren's syndrome: Increased expression in peripheral blood of patients with primary Sjogren's syndrome.
    Ji J; Zhang X; Ling Y; Tian J; Wang Y; Luo Y; Zhu R; Zhou Y; Zhu T; Wang L; Zhu H
    Int Immunopharmacol; 2022 Nov; 112():109231. PubMed ID: 36113315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Sjögren's Syndrome: A Retrospective Cohort Study of Burden of Illness in Sweden.
    Westerlund A; Kejs AMT; Beydogan H; Gairy K
    Rheumatol Ther; 2021 Jun; 8(2):955-971. PubMed ID: 34105109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders.
    Lin L; Hang H; Zhang J; Lu J; Chen D; Shi J
    Mult Scler Relat Disord; 2022 Feb; 58():103494. PubMed ID: 35051897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
    Gál I; Lakos G; Zeher M
    Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial Dysfunction in Primary Sjögren's Syndrome: Correlation with Serum Biomarkers of Disease Activity.
    Caraba A; Iurciuc S; Nicolin M; Iurciuc M
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.